Form4insider filings, from the source

SEC Form 4 · accession 0000911916-16-000624

CoLucid Pharmaceuticals, Inc. · CLCD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Thomas P. Mathers
Officer — Chief Executive Officer · Director
Period of report
Jul 5, 2016
Accepted (ET)
Jul 5, 2016 · 4:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348649

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jul 5, 2016M3,755—A252,409D
Common StockF2,F3Jul 5, 2016S1,502$9.73D250,907D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF1,F4—Jul 5, 2016M3,755D——Common Stock3,755127,679D

Explanation of responses